MarketCap
Facebook
X
TelegramCountry |
 USA |
IPO year |
2000 |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
45.1 M |
Market Cap[1] |
$ 1.75 B |
EBITDA (LTM) |
$ 663 K |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
InfuSystem Holdings
INFU
|
$ 11.99 | 0.74 % | $ 248 M | NYSE American | USA |
 |
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | USA |
 |
Repro Med Systems
KRMD
|
$ 3.14 | 0.93 % | $ 145 M | Nasdaq Capital Market | USA |
 |
LeMaitre Vascular
LMAT
|
$ 79.36 | 0.22 % | $ 1.8 B | Nasdaq Global Market,SPB | USA |
 |
Microbot Medical
MBOT
|
$ 1.5 | 3.82 % | $ 68.7 M | Nasdaq Global Select Market |  Israel |
 |
Merit Medical Systems
MMSI
|
$ 87.21 | 1.16 % | $ 5.16 B | Nasdaq Global Select Market,SPB | USA |
 |
Nephros
NEPH
|
$ 4.18 | 2.96 % | $ 44.4 M | Nasdaq Global Select Market | USA |
 |
Envista Holdings Corporation
NVST
|
$ 26.71 | 0.73 % | $ 4.49 B | NYSE | USA |
 |
AngioDynamics
ANGO
|
$ 15.16 | 0.07 % | $ 630 M | Nasdaq Global Select Market | USA |
 |
OraSure Technologies
OSUR
|
$ 3.42 | 2.27 % | $ 251 M | Nasdaq Global Select Market,SPB | USA |
 |
Harvard Bioscience
HBIO
|
$ 7.9 | 0.25 % | $ 351 M | Nasdaq Global Market | USA |
 |
Pro-Dex
PDEX
|
$ 69.68 | 18.88 % | $ 225 B | Nasdaq Global Select Market | USA |
 |
Pulse Biosciences
PLSE
|
$ 49.71 | 3.85 % | $ 3.35 B | Nasdaq Global Select Market | USA |
 |
ResMed
RMD
|
$ 220.54 | 0.04 % | $ 32.1 B | NYSE,SPB | USA |
 |
STAAR Surgical Company
STAA
|
$ 23.98 | 2.17 % | $ 1.19 B | Nasdaq Global Market,SPB | USA |
 |
Stereotaxis
STXS
|
$ 1.33 | 0.36 % | $ 121 M | NYSE American | USA |
 |
Teleflex Incorporated
TFX
|
$ 135.47 | 0.38 % | $ 6.04 B | NYSE,SPB | USA |
 |
Retractable Technologies
RVP
|
$ 0.71 | 2.12 % | $ 21.3 M | NYSE American | USA |
 |
Utah Medical Products
UTMD
|
$ 68.48 | 0.55 % | $ 222 M | Nasdaq Global Select Market | USA |
 |
West Pharmaceutical Services
WST
|
$ 335.3 | 0.03 % | $ 24.2 B | NYSE,SPB | USA |
 |
DENTSPLY SIRONA
XRAY
|
$ 10.98 | 0.48 % | $ 2.19 B | Nasdaq Global Select Market,SPB | USA |
 |
electroCore
ECOR
|
$ 8.97 | 1.1 % | $ 76.1 K | Nasdaq Global Select Market | USA |
 |
Becton, Dickinson and Company
BDX
|
$ 179.1 | 0.05 % | $ 51.5 B | NYSE,SPB | USA |
 |
The Cooper Companies
COO
|
$ 67.86 | 1.31 % | $ 13.5 B | NYSE,SPB | USA |
 |
AtriCure
ATRC
|
$ 52.26 | 1.44 % | $ 2.5 B | Nasdaq Global Market,SPB | USA |
 |
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | USA |
 |
Glaukos Corporation
GKOS
|
$ 182.37 | 2.69 % | $ 10.4 B | NYSE,SPB | USA |
 |
Haemonetics Corporation
HAE
|
$ 102.27 | 0.07 % | $ 4.82 B | NYSE,SPB | USA |
 |
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | USA |
 |
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | USA |
 |
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | USA |
 |
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | USA |
 |
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | USA |
 |
Alcon
ALC
|
$ 69.01 | 0.3 % | $ 34 B | NYSE |  Schweiz |
 |
Baxter International
BAX
|
$ 24.69 | 1.02 % | $ 12.7 B | NYSE,SPB | USA |
 |
BioLife Solutions
BLFS
|
$ 35.75 | 1.42 % | $ 1.71 B | Nasdaq Global Select Market | USA |
 |
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | USA |
 |
ICU Medical
ICUI
|
$ 161.35 | 0.78 % | $ 3.98 B | Nasdaq Global Select Market,SPB | USA |
 |
iRhythm Technologies
IRTC
|
$ 120.74 | 0.77 % | $ 3.86 B | Nasdaq Global Select Market,SPB | USA |
 |
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | USA |
 |
Intuitive Surgical
ISRG
|
$ 351.08 | 0.28 % | $ 125 B | Nasdaq Global Select Market,SPB | USA |
 |
Masimo Corporation
MASI
|
- | - | $ 9.59 B | Nasdaq Global Select Market,SPB | USA |
 |
Milestone Scientific
MLSS
|
$ 0.45 | 0.06 % | $ 36.9 M | NYSE American | USA |
 |
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | USA |
 |
Repligen Corporation
RGEN
|
$ 170.91 | 1.97 % | $ 9.61 M | Nasdaq Global Select Market,SPB | USA |
 |
STERIS plc
STE
|
$ 217.67 | 0.31 % | $ 21.4 B | NYSE,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.